238 related articles for article (PubMed ID: 29077146)
1. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention.
Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention.
Jiang F; Yang J; Zhang L; Li R; Zhuo L; Sun L; Zhao Q
Clin Cardiol; 2014 Sep; 37(9):530-5. PubMed ID: 25156269
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
[TBL] [Abstract][Full Text] [Related]
5. Effects of High-Dose Rosuvastatin on Ventricular Remodelling and Cardiac Function in ST-Segment Elevation Myocardial Infarction.
Luo R; Sun X; Shen F; Hong B; Wang Z
Drug Des Devel Ther; 2020; 14():3891-3898. PubMed ID: 33061295
[TBL] [Abstract][Full Text] [Related]
6. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
7. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
8. Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction.
Liu ZJ; Hu GP; Fei MY; Yin Z; Shi QX; Sun F
Chin Med Sci J; 2018 Jun; 33(2):84-90. PubMed ID: 29976277
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention.
Liu HY; Wang W; Shi DZ; Ge JB; Zhang L; Peng J; Wang CL; Wang PL
Chin J Integr Med; 2012 Jun; 18(6):423-30. PubMed ID: 22382523
[TBL] [Abstract][Full Text] [Related]
10. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
Shehata M; Fayez G; Nassar A
Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
[TBL] [Abstract][Full Text] [Related]
11. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
12. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
14. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
He W; Cao M; Li Z
Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
[TBL] [Abstract][Full Text] [Related]
15. Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial.
Nabati M; Janbabai G; Esmailian J; Yazdani J
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):233-241. PubMed ID: 30599756
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
[TBL] [Abstract][Full Text] [Related]
17. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese Medicine Intervenes Ventricular Remodeling Following Acute Myocardial Infarction: Evidence From 40 Random Controlled Trials With 3,659 Subjects.
Zhang XX; Liang B; Shao CL; Gu N
Front Pharmacol; 2021; 12():707394. PubMed ID: 34531742
[No Abstract] [Full Text] [Related]
19. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
[TBL] [Abstract][Full Text] [Related]
20. Value of three dimensional-speckle tracking imaging for predicting left ventricular function after non-ST-segment elevation myocardial infarction with percutaneous coronary intervention.
Luo Y; Liu Y; Guan X; Zhang Y; Li J
J Xray Sci Technol; 2018; 26(2):331-339. PubMed ID: 29562571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
